Should we regulate people’s access to their own genome data?

August 12, 2010

Back in June, the US Food and Drug Administration fired a warning shot across the bow of the nascent direct-to-consumer (DTC) genetic testing industry. The FDA felt that some of the services were marketing their products as medical tests, and therefore had to provide evidence of their efficacy. Since then, both Congress and the Government Accountability Office have looked into the DTC market, raising the prospects for direct government intervention in the market. (Ars Technica)